StockDriftsStockDriftsTop 1 Trv Gp Ii, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| JNCE | JOUNCE THERAPEUTICS, INC. | 100% | 572.8K | $1K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Trv Gp Ii, Llc reports $1.34K in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is JNCE (100.0%). Figures reflect the Q3 2022 filing.
Sign up free to track Trv Gp Ii, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Trv Gp Ii, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1614073). View Trv Gp Ii, Llc’s 13F filings on SEC